Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center

[1]  N. Jones.  The Manchester Uveitis Clinic: The First 3000 Patients—Epidemiology and Casemix , 2015, Ocular immunology and inflammation.

[2]  J. Forrester,et al.  Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis , 2013, Molecular vision.

[3]  Jennifer Pan,et al.  Noninfectious Immune-Mediated Uveitis and Ocular Inflammation , 2013, Current Allergy and Asthma Reports.

[4]  Herbert Auer,et al.  Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients , 2012, Orphanet Journal of Rare Diseases.

[5]  S. Guerriero,et al.  Treg Lymphocytes in Autoimmune Uveitis , 2012, Ocular immunology and inflammation.

[6]  N. Surendran,et al.  Therapeutic Targeting of STAT3 (Signal Transducers and Activators of Transcription 3) Pathway Inhibits Experimental Autoimmune Uveitis , 2012, PloS one.

[7]  A. Dick,et al.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation , 2012, Eye.

[8]  P. Mitchell,et al.  The role of toll-like receptor variants in acute anterior uveitis , 2011, Molecular vision.

[9]  Reiko Horai,et al.  Cytokines in autoimmune uveitis. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  R. Nussenblatt,et al.  Emerging drugs for uveitis , 2011, Expert opinion on emerging drugs.

[11]  I. Foeldvari,et al.  Cutting-Edge Issues in Autoimmune Uveitis , 2011, Clinical reviews in allergy & immunology.

[12]  J. Rosenbaum,et al.  An Update on the Genetics of HLA B27-associated Acute Anterior Uveitis , 2011, Ocular immunology and inflammation.

[13]  L. Carmona,et al.  Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. , 2011, Seminars in arthritis and rheumatism.

[14]  R. Caspi.  A look at autoimmunity and inflammation in the eye. , 2010, The Journal of clinical investigation.

[15]  M. Khairallah.  Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for Codifying the Site of Inflammation Appropriate for All Uveitis Problems? Limitations of the SUN Working Group Classification , 2010, Ocular immunology and inflammation.

[16]  A. Okada,et al.  Frequency and clinical features of intraocular inflammation in Tokyo , 2009, Clinical & experimental ophthalmology.

[17]  S. Ohno,et al.  Clinical features of intraocular inflammation in Hokkaido, Japan , 2009, Acta ophthalmologica.

[18]  A. Kijlstra,et al.  Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. , 2008, Investigative ophthalmology & visual science.

[19]  N. Kamatani,et al.  Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet’s disease before ocular attack: a possible predictive marker of ocular attack , 2008, Modern rheumatology.

[20]  Phoebe Lin,et al.  Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. , 2008, American journal of ophthalmology.

[21]  S. Rathinam,et al.  Global variation and pattern changes in epidemiology of uveitis. , 2007, Indian journal of ophthalmology.

[22]  M. Mochizuki,et al.  Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. , 2006, Investigative ophthalmology & visual science.

[23]  D. Wakefield,et al.  Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease , 2005, British Journal of Ophthalmology.

[24]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[25]  J. Kalil,et al.  T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. , 2005, Investigative ophthalmology & visual science.

[26]  D. Gritz,et al.  Incidence and prevalence of uveitis in Northern California , 2004 .

[27]  D. Gritz,et al.  Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. , 2004, Ophthalmology.

[28]  H. Kaplan,et al.  The association of HLA class II with pars planitis. , 2001, American journal of ophthalmology.

[29]  L. Tomazzoli,et al.  Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. , 2001, Acta ophthalmologica Scandinavica.

[30]  J. Jover,et al.  Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. , 1997, Arthritis and rheumatism.